LINC01843

Across TCGA pan-cancer cohorts, LINC01843 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC01843 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01843 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01843 expression acts as an unfavorable survival marker, although some lineages such as KIRC and ACC show a favorable association.

KIRC, ACC, and LUAD are the cancer types where LINC01843 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.764	0.511	<.001	126	view →
ACC	OS	Median	All	0.786	0.468	.001	76	view →
LUAD	DFS	Median	All	0.263	0.430	<.001	56	view →
READ	DFS	Median	II,III,IV	0.849	0.391	.005	40	view →
LGG	DFS	Tertile	All	0.267	0.444	<.001	32	view →
LUSC	OS	Quartile	II,III,IV	0.474	0.718	.002	31	view →
LIHC	DFS	Quartile	All	0.310	0.590	.008	31	view →
PAAD	OS	Quartile	All	0.401	0.590	.011	19	view →
BRCA	OS	Quartile	III,IV	0.905	0.728	.005	18	view →
SARC	OS	Tertile	All	0.828	0.611	.006	16	view →
GBM	DFS	Tertile	All	0.168	0.290	.017	15	view →
UCEC	DFS	Tertile	IV	0.302	0.687	.038	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC01843–KIRC (OS)

Open the KIRC breakdown →